Physician profile
David Chan
NPI 1497289961
$3,921.87
in general payments reported to CMS, 2019-2025
25 companies · $262 in 2025
The $262 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $66.30 · 2021: $1,410 · 2022: $1,477 · 2023: $297 · 2024: $410 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $968.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $2,400.00 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $304.72 | 2024-2025 | Purified Cortrophin Gel |
| Smith+Nephew, INC. | $281.36 | 2021-2024 | Grafix, Memofix Super Elastic Nitinol Staple System, Mba Titanium Subtalar Implant System |
| Averitas Pharma INC. | $158.51 | 2023-2025 | Qutenza |
| Organogenesis INC. | $102.78 | 2023-2024 | Affinity, Puraply |
| Integra Lifesciences Corporation | $69.30 | 2020-2022 | |
| Amgen INC. | $67.87 | 2024-2025 | Krystexxa |
| Kowa Pharmaceuticals America, INC. | $63.55 | 2023 | Seglentis |
| Kerecis Limited | $51.97 | 2021 | |
| Horizon Therapeutics Plc | $48.67 | 2022 | |
| Heron Therapeutics, INC. | $46.94 | 2021-2023 | Zynrelef |
| Fidia Pharma USA INC. | $46.47 | 2022-2023 | Hymovis, Triluron |
| Medtronic, INC. | $39.91 | 2022-2025 | Inceptiv |
| Osteomed LLC | $38.98 | 2022 | |
| Wright Medical Technology, INC. | $34.57 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $29.90 | 2023 | |
| Triad Life Sciences INC. | $24.78 | 2022 | |
| Paratek Pharmaceuticals, INC. | $17.39 | 2024 | Nuzyra |
| Depuy Synthes Sales INC. | $16.64 | 2025 | Healix Knotless Peek, Dynacord |
| Stryker Corporation | $16.44 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.38 | 2021 | |
| Hikma Pharmaceuticals USA | $12.97 | 2021 | |
| Bioventus LLC | $11.92 | 2021 | |
| Paragon 28, INC. | $11.13 | 2020 | |
| Orthofix Medical, INC. | $9.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.